Seguir
Jason Park
Jason Park
Flagship Pioneering
Dirección de correo verificada de flagshippioneering.com
Título
Citado por
Citado por
Año
Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease
BR Stockwell, JPF Angeli, H Bayir, AI Bush, M Conrad, SJ Dixon, S Fulda, ...
Cell 171 (2), 273-285, 2017
46392017
Label-free biomarker detection from whole blood
E Stern, A Vacic, NK Rajan, JM Criscione, J Park, BR Ilic, DJ Mooney, ...
Nature nanotechnology 5 (2), 138-142, 2010
6512010
Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy
J Park, SH Wrzesinski, E Stern, M Look, J Criscione, R Ragheb, SM Jay, ...
Nature materials 11 (10), 895-905, 2012
5372012
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin
J Park, PM Fong, J Lu, KS Russell, CJ Booth, WM Saltzman, TM Fahmy
Nanomedicine in Cancer, 575-596, 2017
4452017
Nanosystems for simultaneous imaging and drug delivery to T cells
TM Fahmy, PM Fong, J Park, T Constable, WM Saltzman
The AAPS journal 9, E171-E180, 2007
1542007
Modulation of CD4+ T lymphocyte lineage outcomes with targeted, nanoparticle-mediated cytokine delivery
J Park, W Gao, R Whiston, TB Strom, S Metcalfe, TM Fahmy
Molecular pharmaceutics 8 (1), 143-152, 2011
1372011
Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF)
S Rittchen, A Boyd, A Burns, J Park, TM Fahmy, S Metcalfe, A Williams
Biomaterials 56, 78-85, 2015
1252015
Paracrine co-delivery of TGF-β and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells
MD McHugh, J Park, R Uhrich, W Gao, DA Horwitz, TM Fahmy
Biomaterials 59, 172-181, 2015
1232015
Cell stimulation with optically manipulated microsources
H Kress, JG Park, CO Mejean, JD Forster, J Park, SS Walse, Y Zhang, ...
Nature methods 6 (12), 905-909, 2009
1132009
Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates
J Park, T Mattessich, SM Jay, A Agawu, WM Saltzman, TM Fahmy
Journal of controlled release 156 (1), 109-115, 2011
1002011
Nanomed.: Nanotechnol
HK Patra, S Banerjee, U Chaudhuri, P Lahiri, AK Dasgupta
Biol. Med 3, 111-119, 2007
362007
Paracrine signalling events in embryonic stem cell renewal mediated by affinity targeted nanoparticles
B Corradetti, P Freile, S Pells, P Bagnaninchi, J Park, TM Fahmy, ...
Biomaterials 33 (28), 6634-6643, 2012
342012
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents
TM Fahmy, E Stern, RA Flavell, J Park, A Siefert, SH Wrzesinski
US Patent 9,610,250, 2017
162017
Biodegradable nanoparticles for drug delivery
J Park, TM Fahmy
Handbook of Nanophysics: Nanomedicine and Nanorobotics, 1-14, 2010
92010
Biodegradable nanoparticles for drug delivery
J Park, TM Fahmy
Handbook of Nanophysics: Nanomedicine and Nanorobotics, 1-14, 2010
92010
Development of PTH eluting microspheres for the treatment of hypoparathyroidism
P Fong, A Goyal, M Brennan, J Park, L Moss, WM Saltzman, CK Breuer
Journal of Surgical Research 143 (2), 195-199, 2007
72007
Heart valves
PM Fong, J Park, CK Breuer
Principles of Tissue Engineering, Third Edition, 585-601, 2007
52007
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents
TM Fahmy, E Stern, RA Flavell, J Park, A Siefert, SH Wrzesinski
US Patent 10,603,276, 2020
42020
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents
TM Fahmy, E Stern, RA Flavell, J Park, A Siefert, SH Wrzesinski
US Patent App. 17/399,544, 2022
2022
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents
TM Fahmy, E Stern, RA Flavell, J Park, A Siefert, SH Wrzesinski
US Patent 11,173,119, 2021
2021
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20